Selective ligands of human constitutive androstane receptor

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61388963%3A_____%2F22%3A00573123" target="_blank" >RIV/61388963:_____/22:00573123 - isvavai.cz</a>
Result on the web
<a href="https://worldwide.espacenet.com/patent/search/family/070464788/publication/AU2020264679B2?q=AU2020264679B2" target="_blank" >https://worldwide.espacenet.com/patent/search/family/070464788/publication/AU2020264679B2?q=AU2020264679B2</a>
DOI - Digital Object Identifier
—

Result language
angličtina
Original language name
Selective ligands of human constitutive androstane receptor
Original language description
The present invention provides a structurally novel class of heterocyclic compounds of general formula I wherein L1 is heteroaryl and L2 is heteroaryl or aryl. The novel compounds are useful in a method of prevention or treatment of a condition which is mediated by the action, or by loss of action, of Constitutive androstane receptor (CAR) receptor or its endogenous ligands. The present invention thus provides the novel compounds for medicinal use, as well as pharmaceutical composition containing said compounds. (I)
Czech name
—
Czech description
—

Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2022
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Patent/design ID
AU2020264679
Publisher
AU001 -
Publisher name
IP Australia
Place of publication
Phillip ACT
Publication country
AU - AUSTRALIA
Date of acceptance
Dec 8, 2022
Owner name
Ústav organické chemie a biochemie AV ČR, v. v. i. - Univerzita Karlova
Method of use
B - Výsledek je využíván orgány státní nebo veřejné správy
Usage type
A - K využití výsledku jiným subjektem je vždy nutné nabytí licence

Similar results(10)